Konishi, MasanoriErdem, Sultan SibelWeissleder, RalphLichtman, AndrewMcCarthy, JasonLibby, Peter10.07.20192019-07-1010.07.20192019-07-102015Konishi, M., Erdem, S. S., Weissleder, R., Lichtman, A., McCarthy, J. ve Libby, P. (2015). Imaging Granzyme B activity assesses immune-mediated myocarditis. Circulation Research, 117(6), 502-512. https://dx.doi.org/10.1161/CIRCRESAHA.115.3063640009-73301524-4571https://dx.doi.org/10.1161/CIRCRESAHA.115.306364https://hdl.handle.net/20.500.12511/2158WOS: 000360142000006PubMed ID: 26199323Rationale: The development of molecular imaging approaches that assess specific immunopathologic mechanisms can advance the study of myocarditis. Objective: This study validates a novel molecular imaging tool that enables the in vivo visualization of granzyme B activity, a major effector of cytotoxic CD8(+) T lymphocytes. Methods and Results: We synthesized and optimized a fluorogenic substrate capable of reporting on granzyme B activity and examined its specificity ex vivo in mice hearts with experimental cytotoxic CD8(+) T lymphocyte-mediated myocarditis using fluorescence reflectance imaging, validated by histological examination. In vivo experiments localized granzyme B activity in hearts with acute myocarditis monitored by fluorescent molecular tomography in conjunction with coregistered computed tomography imaging. A model anti-inflammatory intervention (dexamethasone administration) in vivo reduced granzyme B activity (vehicle versus dexamethasone: 504263 versus 194 +/- 77 fluorescence intensities in hearts; P=0.002). Conclusions: Molecular imaging of granzyme B activity can visualize T cell-mediated myocardial injury and monitor the response to an anti-inflammatory intervention.eninfo:eu-repo/semantics/openAccessDexamethasoneGranzymeImmunologyMolecular ImagingMyocarditisArticle117650251210.1161/CIRCRESAHA.115.306364Q1Q1